Class III
Terminated
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd.
Why: Subpotent Drug.
- Company
- Teva Pharmaceuticals USA
North Wales, PA, United States - Reported
- Mar 27, 2019
- Recall started
- Mar 11, 2019
- Ended
- Nov 15, 2019
- Where sold
- Nationwide in the United States.
- Amount
- 7,081 bottles
- Full product description
- Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93
- Lots / codes affected
- Lot #: 25Q002, Exp. 11/2019
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.